Chemical finger-printing, antioxidant activity and in silico validation of phytometabolites of Octhochloa compressa
Abstract
This study focused on evaluating the antioxidant properties of Octhochloa compressa, a Cholistani medicinal plant and to explore the interaction of its active phytochemical constituents with the biological macromolecule NADPH oxidase (PDB ID: 2CDU). Six different non-polar to polar solvent extracts were evaluated for their antioxidant activity using DPPH and FRAP assays. The key metabolites were then subjected to molecular docking against NADPH oxidase, density functional theory (DFT) and molecular dynamics (MD) simulations to validate the ligand-protein stability and conformational dynamics. The methanol extract revealed significantly highest scavenging potential (IC50 = 110 ± 2.34 µg/mL) in DPPH assay and displayed the greatest amount of total phenolic (97.34 ± 3.34 mg GAE/g) and flavonoid (98.72 ± 2.46 µg CE/g) contents. Phytochemical profiling of the methanol extract identified 43 major bioactive compounds by using HPLC and GC-MS. Silico molecular docking of selected metabolites (lignan, oxindole, apigenin, anthocyanin, acridone) with NADPH oxidase revealed stable interactions, with binding energies ranging from - 6.060 to -6.654 kcal/mol. DFT analysis revealed dipole moments of 1.36-7.52 D and HOMO-LUMO gaps of 3.15-11.74 eV with anthocyanin and apigenin, predicted as the most reactive ligands. MD simulations further confirmed these findings, as the representative 2CDU-ligand complex rapidly equilibrated and maintained the stability across 1 ns and 10 ns trajectories…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.